DrugBank ID: db10500
DrugCentral: almond
Synonymous : None

Drug Sentece Context

Table 1. Analysis of context sentence of almond gene in 5 abstracts.

pmid sentence
32963884 Of the 65 compounds, only three, namely, 3-galloylcatechin, proanthocyanidin B1, and luteolin 7-galactoside found in almond (Terminalia catappa), grape (Vitis vinifera), and common verbena (Verbena officinalis), were able to bind to all eight targets better than the reported repurposed drugs.
33292385 Among them, ephedra-bitter almond is a common couplet medicine in anti-COVID-19 prescriptions. […] This study aims to conduct an exploration of key components and mechanisms of ephedra-bitter almond anti-COVID-19 based on network pharmacology. […] We collected and screened potential active components of ephedra-bitter almond based on the TCMSP Database, and we predicted targets of the components. […] Then, the potential targets of ephedra-bitter almond against COVID-19 were screened out. […] The key components, targets, biological processes, and pathways of ephedra-bitter almond anti-COVID-19 were predicted by constructing the relationship network of herb-component-target (H-C-T), protein-protein interaction (PPI), and functional enrichment. […] Ephedra-bitter almond played an overall regulatory role in anti-COVID-19 via the patterns of multi-component-target-pathway. […] In addition, some key components of ephedra-bitter almond, such as β-sitosterol, estrone, and stigmasterol, had high binding activity to 3CL and ACE2 by molecular docking simulation, which provided new molecular structures for new drug development of COVID-19.